N. YILMAZ Et Al. , "Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation," RENAL FAILURE , vol.38, no.8, pp.1300-1309, 2016
YILMAZ, N. Et Al. 2016. Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation. RENAL FAILURE , vol.38, no.8 , 1300-1309.
YILMAZ, N., Ustundag, Y., KIVRAK, Ş., Kahvecioglu, S., Celik, H., KIVRAK, İ., ... Huysal, K.(2016). Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation. RENAL FAILURE , vol.38, no.8, 1300-1309.
YILMAZ, NİGAR Et Al. "Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation," RENAL FAILURE , vol.38, no.8, 1300-1309, 2016
YILMAZ, NİGAR Et Al. "Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation." RENAL FAILURE , vol.38, no.8, pp.1300-1309, 2016
YILMAZ, N. Et Al. (2016) . "Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation." RENAL FAILURE , vol.38, no.8, pp.1300-1309.
@article{article, author={NİGAR YILMAZ Et Al. }, title={Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation}, journal={RENAL FAILURE}, year=2016, pages={1300-1309} }